Does ticagrelor reduce the rate of stroke, myocardial infarction, or death at 90 days compared to aspirin in patients with acute ischemic stroke or transient ischemic attack?
Patients with acute ischemic stroke or transient ischemic attack
Ticagrelor
Aspirin
Composite of stroke, myocardial infarction, or death at 90 dayscomposite
In patients with acute ischemic stroke or transient ischemic attack, ticagrelor is not superior to aspirin for preventing the composite of stroke, myocardial infarction, or death at 90 days.
In our trial involving patients with acute ischemic stroke or transient ischemic attack, ticagrelor was not found to be superior to aspirin in reducing the rate of stroke, myocardial infarction, or death at 90 days. (Funded by AstraZeneca; ClinicalTrials.gov number, NCT01994720.).
Building similarity graph...
Analyzing shared references across papers
Loading...
S. Claiborne Johnston
Pierre Amarenco
Gregory W. Albers
New England Journal of Medicine
Harvard University
University of California, San Francisco
Chinese University of Hong Kong
Building similarity graph...
Analyzing shared references across papers
Loading...
Johnston et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69d56f6675589c71d767d825 — DOI: https://doi.org/10.1056/nejmoa1603060